Purcell to run Perseus-Soros venture

Dennis Purcell was to announce today that he is leaving his banking post at Chase H&Q to join Perseus-Soros Biopharmaceutical Fund, a new limited partnership that will invest in life science companies.

The goal of the fund, according to Purcell, is to provide life science companies with an alternative to public equity and big pharma money, giving them time to create value in their internally developed programs prior to partnering them off. ...